Filing metadata

Accession number
0001127602-23-015029
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
May 09, 2023
Reporting period
May 08, 2023
Description
Insider transaction

Explore SEC Filings Hub